Skip to content

Effects of a Comprehensive Intervention on Blood Pressure Control in a Primary Care Setting

Effects of a Comprehensive Intervention on Blood Pressure Control in a Primary Care Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01915199
Enrollment
144
Registered
2013-08-02
Start date
2000-10-31
Completion date
Unknown
Last updated
2014-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The implementation of lifestyle modifications, home blood pressure (BP) measurement, and optimization of antihypertensive drug therapy have been shown to improve BP control in tightly controlled research settings. The investigators objective is to determine the effect of these interventions in a primary care setting, with the family practitioners and nurses serving as the interventionists. The investigaotrs hypothesis is that a comprehensive intervention performed in a primary care setting would lead to better blood pressure control.

Interventions

OTHERIntensive Care

Comprehensive intervention on hypertension through optimization of drug therapy, introduction of home blood pressure monitoring, and lifestyle guidance

Sponsors

City of Turku
CollaboratorOTHER_GOV
Social Insurance Institution, Finland
CollaboratorOTHER
Finnish Institute for Health and Welfare
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* Aged 35-74 years * Untreated office blood pressure of ≥ 160/100 mmHg or on active antihypertensive treatment.

Exclusion criteria

* Severe psychiatric or neurologic illnesses * Heart failure (ejection fraction \< 40% or previous hospitalization for heart failure) * Hemodynamically significant valvular disease * Unstable coronary heart disease * Chronic kidney disease (proteinuria \> 1 g/l or a serum creatinine concentration \> 160 mmol/l)

Design outcomes

Primary

MeasureTime frame
Change in Office Systolic and Diastolic Blood PressureBaseline and at 12 Months.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026